MSM. A. Sagirov

M. A. Sagirov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


M. A. Sagirov has a total of 86 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Use of Labeled Autoleukocytes in a Patient with Prolonged Fever After Supracoronary Ascending Aorta Replacement for Acute Dissection

    by E. V. Migunova, D. V. Bikhert, T. V. Bognitskaya, N. S. Dyakun, G. A. Nefedova, M. A. Sagirov, V. S. Selyaev, V. P. Nikulina, L. T. Khamidova, Е. В. Мигунова, et al.

    RELEVANCE. Infectious endocarditis, which develops both early and late after vascular reconstructions, remains one of the most severe and prognostically unfavorable causes of complications. One of the life-threatening consequences may be the formation of a pseudoaneurysm of the ascending aorta, associated with tissue destruction in the area of sutures and anastomoses. In such clinical situations, standard imaging methods do not always allow for accurate localization of the inflammatory process. Scintigraphy with 99mTc-theoxime-labeled leukocytes is a highly informative diagnostic method that allows for the localization and extent of the infectious focus, including systemic manifestations. AIM OF THE STUDY. Demonstration of the diagnostic and clinical significance of 99mTc-theoxime-labeled autoleukocyte scintigraphy in the case of suspected infectious endocarditis complicated by ascending aortic pseudoaneurysm formation and systemic inflammatory reaction. MATERIAL AND METHODS A 59-year-old patient with clinical manifestations of prolonged fever and a history of supracoronary replacement of the ascending aorta for acute aortic dissection underwent scintigraphy with labeled autoleucocytes, including the “whole body” mode, SPECT and SPECT/CT. Labeling was carried out in vitro with subsequent introduction of the drug and scanning after 1 and 4.5 hours. RESULTS.  Leukocyte-labeled scintigraphy revealed focal accumulation of radiopharmaceuticals in the projection of the ascending aortic vascular prosthesis, as well as in the area of the sternum and myocardium. Additionally, there was a decrease in accumulation in the spleen. Ultrasound examination confirmed signs of ischemia and fibrous transformation of the spleen parenchyma. CT angiography revealed signs of inflammation in the distal anastomosis area. Anastomositis with pronounced inflammatory infiltration, areas of granulation tissue, and giant cell reaction was morphologically verified. The performed surgical intervention led to stabilization of the condition, and clinical and laboratory remission. CONCLUSION. The development of a pseudoaneurysm of the ascending aorta in the presented case was a complication of infectious endocarditis. Scintigraphy with labeled leukocytes provided high diagnostic accuracy in the context of clinical uncertainty, allowing for the detection of both local and systemic manifestations of inflammation, including splenic ischemia, and became a determining factor in the choice of surgical tactics.

  • Open Access

    Development of a Left Atrioesophageal Fistula after Radiofrequency Catheter Ablation for the Treatment of Atrial Fibrillation

    by V. V. Vladimirov, A. V. Kuklyaev, R. Sh. Muslimov, E. V. Tatarinova, I. V. Ivanov, M. A. Sagirov, A. D. Arutyunyan, L. R. Tigiev, В. В. Владимиров, А. В. Кукляев, et al.

    BACKGROUND. The increasing use of radiofrequency catheter ablation (RFCA) for the treatment of atrial fibrillation (AF) has led to a rise in complication rates. Among the complications of radiofrequency catheter ablation, atrioesophageal fistula, although rare, is fatal. CASE DESCRIPTION. This article presents a clinical observation of a 71-year-old patient who underwent surgery for an atrioesophageal fistula that developed as a complication of cardiac radiofrequency catheter ablation. CONCLUSION. Atrioesophageal fistula is a very rare, life-threatening complication following RFCA. A multidisciplinary approach is key to early diagnosis. Despite unsuccessful attempts at surgical separation of the atrioesophageal fistula, we are absolutely confident that surgical intervention is the only option that can save the patient’s life. Only early diagnosis, prompt work by a multidisciplinary team, and a comprehensive approach can ensure a favorable outcome.

  • Mechanical Circulatory Support in Patients with End-Stage Heart Failure: a Literature Review (Part 2)

    by M. Sh. Khubutiya, A. S. Tokarev, N. V. Rubtsov, M. V. Israpiev, I. G. Khutsishvili, M. A. Sagirov, I. A. Argir

    This article reviews modern technologies for durable mechanical circulatory support (dMCS) —implantable devices that replace or support cardiac function. The process of improving circulatory support devices has spanned several decades. We have evolved from bulky first-generation pulsatile pumps to compact and reliable non-pulsatile flow pumps. Today, these highly effective systems are used in 95% of cases. Modern devices can serve not only as a bridge to heart transplantation for patients awaiting a donor organ, but also as ongoing therapy for patients who are not eligible for a heart transplant. At the same time, trends toward improving the quality of medical care are also impacting the refinement of existing circulatory support techniques: minimally invasive devices for full and partial cardiac support are being developed; fully magnetically levitated centrifugal-flow left ventricular assist devices are becoming dominant; solutions for right ventricular and biventricular failure, including the total artificial heart, are emerging. Sputnik portable circulatory support devices and STREAM CARDIO systems have been developed and are being used in Russia. They are comparable in efficacy and safety to their foreign counterparts, and in some respects (for example, antithrombogenic coating) they are superior. Their main advantage is their significantly lower cost and accessibility for Russian patients, which is critically important given the shortage of donor organs and the high cost of imported systems. DMCS has become a life-saving and life-preserving standard practice in cardiac surgery. Given current demographic conditions, the growing proportion of patients with heart failure, and the chronic shortage of donor organs, further development and cost reduction of the aforementioned technologies is a strategic necessity for this country.

  • Open Access

    The frozen elephant trunk technique for hyperacute aortic dissection type A

    by V. V. Vladimirov, А. В. Редкобородый, V. S. Selyaev, I. V. Ivanov, R. Sh. Muslimov, M. A. Sagirov, L. S. Kokov

    Introduction . Acute aortic dissection is a current and urgent problem in modern cardiac surgery. In the early stages of the dissection, the surgeon is faced with the dilemma of choosing the volume of intervention from the ascending part reconstruction only or radically ascending and aortic arch replacement. Hybrid systems for one-stage reconstruction of the thoracic aorta are currently being actively developed. The Frozen Elephant Trunk (FET) technique allow us to replacement ascending and arch of the aortae combined with antegrade stent grafting into the descending aorta from the classical sternotomy access. This type of operation doesn’t increase the time of the intervention, there isn’t stage-by-stage reconstruction of the aorta, adequate blood flow in the descending aorta and aortic vessels is restored, and the risks of an adverse outcome are reduced. Objective . To analyze the results of surgical treatment of acute aortic dissection type A, performed using the FET technique in a multidisciplinary surgical hospital – N.V. Sklifosovsky Research Institute for Emergency Medicine. Material and methods . The research included 18 patients which were operated from 2022 to 2024 in acute stage of aortic dissection. All patients were operated using a hybrid technique FET. Results . Multisystem organ failure developed in 5 patients (27.8%). Four patients (22.2%) required renal replacement therapy due to acute renal failure. In 38.9% of the subjects, prolonged artificial ventilation was complicated by pneumonia. Cerebral complications were observed in 6 patients (33.3%). Sepsis accompanied the course of the disease in 16.7% of cases. The 30-day mortality was 22.2%, in the study group. Conclusion . Using the hybrid prosthesis allowed us to obtain relatively satisfactory results of reconstruction thoracic aortae in case of the acute dissection in the early postoperative period.

  • Open Access

    Selective cerebral perfusion during total hypothermic circulatory arrest in surgical treatment of acute thoracic aortic dissection

    by S. V. Zhuravel, I. V. Ivanov, V. V. Vladimirov, M. A. Sagirov, V. E. Statsura, N. S. Dolgasheva, I. I. Goncharova, N. K. Kuznetsova, A. M. Talyzin, L. S. Kokov

    Background . Surgical treatment of acute thoracic aortic dissection is often associated with the need for selective cerebral perfusion at the stage of total hypothermic circulatory arrest. Objective . To establish the preferred method and mode of selective cerebral perfusion (SCP) during complete hypothermic circulatory arrest in surgical treatment of acute thoracic aortic dissection. Material and methods . Study design: prospective, cohort, single-center. Inclusion criteria: surgical intervention using cardiopulmonary bypass, confirmed diagnosis of acute aortic dissection type A according to Stanford, age > 18 years. The study included 112 patients: 77 men and 32 women aged 31 to 75 years, M±SD=54.79±11.33. All patients (n=112) were treated between 2019 and 2023 and were divided into 3 groups depending on the method of selective cerebral perfusion: antegrade unilateral perfusion (n=51), antegrade bilateral perfusion (n=49), and retrograde perfusion (n=12). The endpoints of the study were cerebrovascular accident (CVA) in the early postoperative period and 30-day in-hospital mortality. Results . In the bilateral antegrade cerebral perfusion group (biACP), the incidence of CVA in the early postoperative period (p=0.002) and 30-day in-hospital mortality (p=0.006) were statistically significantly lower. Acute cerebral circulatory failure in the postoperative period increases the risk of death by 7.977 times. The volumetric rate of selective perfusion in biACP is a statistically significant predictor of death, and biACP > 12.5 ml/kg/min when calculated for the true body weight according to Broc is associated with an increased risk of hospital mortality. Conclusions . Bilateral antegrade cerebral perfusion is the preferred technique for selective cerebral perfusion as part of the cardiopulmonary bypass procedure in the surgical treatment of acute thoracic aortic dissection. Restrictive biACP tactics can reduce the risk of 30-day hospital mortality.

  • Open Access

    Long-term prognosis after orthotopic heart transplantation

    by M. Sh. Khubutiya, Kh. G. Alidzhanova, A. V. Dyatlov, S. Yu. Shemakin, M. A. Sagirov, M. Kh. Mazanov

    Introduction . The problem of treating chronic heart failure (CHF) remains one of the most important challenges in cardiology. Despite advances in pharmacotherapy of cardiovascular diseases and the use of the entire arsenal of existing treatment methods, heart transplantation remains the only radical treatment for patients with end-stage heart failure that can significantly improve their prognosis and quality of life. Objective . To investigate the morbidity, the structural-functional state of the myocardium, and mortality of recipients after orthotopic heart transplantation (OHT) in the long term. Material and methods . The study included 50 recipients (44 males and 6 females) who underwent OHT at the N.V. Sklifosovsky Research Institute for Emergency Medicine. The mean age of the patients was 51.2±10.5 years. The mean follow-up period after OHT was 6.5±1.5 years. Results . In the long term after OHT, 16% of recipients were considered healthy; the others were diagnosed with chronic heart failure (CHF) with preserved left ventricular (LV) ejection fraction of functional classes I and II (86%); arterial hypertension (50%); and ischemic heart disease (IHD) without hemodynamic stenosis of the coronary arteries (98%). Normal values of LV global longitudinal and circumferential myocardial strain suggested that after 6 years, the adaptive functions of the heart in transplant recipients was restored, indicating a favorable outcome, confirmed by the absence of remodeling of the right heart chambers and restoration of work capacity (77%). In the long term, side effects of immunosuppressive therapy (oncopathology, post-transplant hypertension, nephropathy, and infections) were observed, which did not differ in frequency from the results of other studies. The mortality rate was 42%. After 1 year, 11.3% had died, and thereafter the mortality rate was 4–6% per year. The highest mortality rate was observed in the first 3 years post-OHT. The main causes of death in the long term were oncological diseases, chronic graft rejection and sudden cardiac death. Conclusion . In the long term after OHT, 16% of recipients were considered healthy; 77% were capable of work. After 6 years of follow-up, the adaptive functions of the heart in recipients were restored. The long-term mortality rate was 4–6% per year.


  • Open Access

    Mechanical Circulatory Support in Patients with End-Stage Heart Failure: a Literature Review (Part 1)

    by M. Sh. Khubutiya, A. S. Tokarev, N. V. Rubtsov, M. V. Israpiev, L. G. Khutsishvili, M. A. Sagirov, I. A. Argir

    Chronic heart failure (CHF) is a progressive and irreversible syndrome that develops against the background of structural and functional disorders of the heart. It is accompanied by a decrease in cardiac output, pressure overload and a high level of hospitalizations, which makes CHF one of the key medical and social problems of our time. In recent decades, the prevalence of CHF has been steadily increasing, especially among the elderly population, which is associated with an increase in life expectancy and an improvement in the quality of medical care. According to forecasts, by 2050 the number of patients will increase by 50-60% compared to 2010.The terminal stage of CHF is characterized by an extremely unfavorable prognosis: survival does not exceed 25-30%. Heart transplantation (HT) remains the only radical treatment method that can significantly improve survival and quality of life. However, the shortage of donor organs and the growing number of patients necessitate the use of mechanical circulatory support (MCS) as a temporary or long-term alternative.MPC systems act as a “bridge” to transplantation, allowing for hemodynamic stabilization and organ function support before surgery. The most common short-term support technologies are extracorporeal membrane oxygenation (ECMO), intra-aortic balloon pump (IABP), and temporary axial pumps (Impella, TandemHeart). ECMO provides both respiratory and hemodynamic support, but is associated with a high risk of complications and relatively low survival. IABP is the most accessible method, improving coronary perfusion, but provides limited support. Impella devices demonstrate higher efficiency, unloading the left ventricle and improving systemic hemodynamics, while being characterized by fewer complications. TandemHeart provides a comparable effect, but requires a more complex installation technique.The choice of MPC method depends on the patient’s condition, the severity of multiorgan dysfunction, the availability of equipment, and the qualifications of the specialists. Current research confirms that a combination of different devices (e.g., ECMO and Impella) can improve outcomes.Thus, mechanical circulatory support occupies a central place in the treatment of terminal heart failure in conditions of limited donor resources, allowing to gain time before transplantation and reduce mortality on the waiting list.


  • Open Access

    Effect of Cardiac Resynchronization Therapy on Reverse Left Ventricular Remodeling in Patients with Functional Class II Heart Failure

    by P. V. Chernyavsky, N. M. Bikbova, M. G. Ivanov, S. Yu. Kambarov, L. S. Kokov, M. Kh. Mazanov, M. A. Sagirov, A. V. Dublev, A. V. Timerbaev

    Introduction. Implantation of a cardioverter-defibrillator reduces the risk of sudden cardiac death caused by the development of ventricular tachycardia (VT) and ventricular fibrillation (VF) of the heart, but implantation of this device does not improve the function of the left ventricle (LV). Modern implantable cardioverter-defibrillators (ICD) with endocardial electrodes allow for optimal treatment of cardiac arrhythmias in heart failure (HF) due to the function of electrical cardiac pacing. Cardiac resynchronization therapy (CRT) is aimed at synchronizing contractions of the opposite walls of the LV, which leads to an improvement in the inotropic function of the heart, and subsequently to reverse remodeling of the LV geometry.The obtained results of the study made it possible to determine whether there was an improvement in volume changes, cardiac function and shock rate when using CRT in combination with an ICD (CRT-D) in patients with HF accompanied by LV dysfunction and a wide QRS complex.Aim of Study. To assess whether CRT in combination with ICD has an effect on LV reverse remodeling in patients with functional class (FC) II HF.Material and Methods. A total of 35 patients with a wide QRS complex >130 ms were included in the study: 15 patients in the CRT-D group and 20 with ICD. The obtained results of the study were interpreted one year after the start of treatment in all patients. Changes in the volumes and contractility of the ventricles of the heart were analyzed in both groups. An assessment was made of the dependence of these changes on the results of treatment in subsequent years.Results. In patients in the CRT-D group, compared with the ICD group, there was an improvement in the LV end-diastolic volume index (-18.7 vs. 8.6 ml/m2), LV end-systolic volume index (-22.5 vs. 5.2 ml/m2), LV ejection fraction (13.2 vs. 0.4%), left atrial volume index (-16.8 vs. 2.7 ml/m2), and pulmonary artery systolic pressure (-11.4 vs. 1.4 mmHg), p < 0.05 for all parameters. The improvement in LV functional parameters 1 year after treatment was reflected in a decrease in mortality and recurrence of HF in these patients in the long-term period (13% in the CRT-D group vs. 50% in the ICD group, p < 0.05). During the first year of observation, one to two shocks for VT/VF were administered in two patients with CRT-D and three patients with an implanted ICD. During the subsequent three-year observation period, the defibrillation function was activated in two more patients in the CRT-D group and in two patients with an implanted ICD.Conclusion. Cardiac resynchronization therapy combined with an implantable cardioverter -defibrillator improves cardiac performance in patients with class II heart failure. Our study demonstrated a decrease in end-diastolic volume, end-systolic volume, left atrial volume, an increase in left ventricular ejection fraction, and an improvement in right ventricular function in patients treated with combined cardiac resynchronization therapy and an implantable cardioverter -defibrillator compared with those treated with an implantable cardioverter-defibrillator alone. These results were consistent with improved outcomes, and outcomes at 1 year were directly related to the degree of improvement in ventricular volumes and function.


  • Open Access

    Modern Aspects of Diagnosis and Treatment of Dilated Cardiomyopathy With Remodeling of the Right Heart

    by M. Sh. Khubutiya, Kh. G. Alidzhanova, Zh. V. Molchanova, M. A. Sagirov, E. V. Ilyina

    Dilated cardiomyopathy (DCM) is the second most common cause of chronic heart failure, and a leading indication for heart transplantation. In the early stages of the disease, many patients are asymptomatic, but they have a high risk of developing life-threatening ventricular arrhythmias (VA) and sudden cardiac death (SCD). Modern methods of DCM diagnosis, such as MRI of the heart, speckle tracking and 3D echocardiography, have convincingly proved the development of structural and functional changes of the right heart (RH) in patients with DCM, their prognostic and therapeutic significance. By MRI of the heart, myocardial fibrosis (MF) is diagnosed, which occurs in the early stages of DCM. Progressive fibrosis is observed in one fifth of patients and is associated with a more than a 3-fold increase in the risk of death and complications of chronic heart failure (CHF). With adequate pharmacological and hardware treatment, reverse heart remodeling occurs in some patients. However, optimal and long-term drug therapy does not lead to MF regression even in individuals with improved left ventricular (LV) function. Remodeling of the RH, regardless of LV ejection fraction (EF), is a predictor of SCD, indicates the progression of the disease, foreshadowing an unfavorable outcome. The prevalence of RH remodeling has not been reliably determined; however, systolic dysfunction of the right ventricle was registered in 34-65% of patients with DCM. The annual and subsequent mortality of patients with DCM remains high.MRI of the heart with contrast enhancement has become the gold standard for the diagnosis of DCM and crucial for the stratification of risk and prognosis of the disease. The treatment of patients with DCM is a complex process. Adequate drug and instrumental therapy in 40% of cases leads to reverse remodeling of the heart, which may be unstable.

  • Open Access

    Predictors of in-hospital mortality in emergency surgical treatment involving cardiopulmonary bypass for acute Stanford type A aortic dissection: a retrospective cohort study

    by Сергей Владимирович Журавель, I. V. Ivanov, V. V. Vladimirov, M. A. Sagirov, А. В. Редкобородый, I. S. Sergeeva, L. S. Kokov

    INTRODUCTION: Acute Stanford type A aortic dissection is one of the most severe cardiovascular diseases with high in-hospital mortality. OBJECTIVE: To establish predictors of in-hospital mortality in the treatment of patients with acute Stanford type A aortic dissection under conditions of artificial circulation and to determine their threshold values. MATERIALS AND METHODS: Study design: retrospective, cohort, single-center. Inclusion criteria: surgical intervention with cardiopulmonary bypass, confirmed diagnosis of acute Stanford type A aortic dissection, age > 18 years. The study included 51 patients: 42 men and 9 women aged from 35 to 77 years, median 59 years [47; 65]. All patients (n = 51) were treated in 2022 and were divided into 2 groups depending on the outcome: group 1 (n = 27) included those who died in the intensive care unit within 30 days, group 2 (n = 24) included survived and discharged patients. The endpoint of trial was 30-day in-hospital mortality. RESULTS: Postoperative Sequential Organ Failure Assessment (SOFA) score > 7, Acute Physiology And Chronic Health Evaluation (APACHE) II score > 19, and Vasoactive-inotropic score (VIS) > 10, cardiopulmonary bypass time > 177 minutes, and total hypothermic circulatory arrest time > 30 minutes were associated with an increased risk of 30-day in-hospital mortality. CONCLUSIONS: Statistically significant predictors of hospital mortality in the treatment of patients with acute Stanford type A aortic dissection under cardiopulmonary bypass are the SOFA index, the APACHE II index and the VIS index after the end of surgery, as well as the time of cardiopulmonary bypass and the time of total hypothermic circulatory arrest.